Near-death states reported in a sample of 50 misusers

Substance Use and Misuse

Volumn 45, Issue 6, 2010, Pages 916-924

  Corazza, Ornella ^a   Schifano, Fabrizio ^a  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Drug misuse; Ketamine; Near death experiences (NDEs); Out of bodyexperiences (OBEs)

Indexed keywords

ANALGESIC AGENT; KETAMINE;

ADDICTION; ADULT; AGED; ARTICLE; DEATH; FEMALE; HUMAN; INTERVIEW; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; UNITED KINGDOM;

ADULT; AGED; ANALGESICS; DEATH; FEMALE; HUMANS; INTERVIEWS AS TOPIC; KETAMINE; LONDON; MALE; MIDDLE AGED; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 77951810725     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826080903565321     Document Type: Article

References (29)

1. Bell, R., Dahl, J., Moore, R., Kalso, E. (2006). Perioperative ketamine for acute postoperative pain. Emergency Medicine Australasia, 18:37-44.
2. Blanke, O., Ortigue, S., Landis, T., Seeck, M. (2002). Stimulating illusory own-body perceptions. Nature, 419:269-270.
3. Bonta, I. L. (2003). Schizophrenia, dissociative anaesthesia and near-death experience; three events meeting at the NMDA receptor. Medical Hypotheses, 62:23-28.
4. Comer, N. L.,Madow, L., Dizon, J. L. (1967). Observation of sensory deprivation in a life-threatening situation. American Journal of Psychiatry, 124:164-169.
5. Corazza, O. (2008). Near-death experiences: exploring the mind-body connection. London: Routledge.
6. Drugscope. (2005). Annual report. Available from:http://www.drugscope. org.uk (accessed January 1 4: 2006).
7. Fenwick, P. (1997). Is the near-death experience only N-methyl-d-aspartate blocking? Journal of Near-Death Studies, 16:43-53.
8. French, C. (2005). Near-Death experiences in cardiac arrest survivals. Progress in Brain Research, 150:351-367.
9. Green, S. M., Clem, K. J., Rothroc, K. S. G. (1996). Ketamine safety profile in the developing world: survey of practitioners. Academy and Emergency Medicine, 3:598-604.
10. Greyson, B. (1983). The Near-Death Experience Scale: construction, reliability, and validity. Journal of Nervous Mental Disease, 171:369-375.
11. Greyson, B., Stevenson, I. (1980). The phenomenology of the Near-Death Experience. American Journal of Psychiatry, 137:1193-1196.
12. Jansen, K. L. R. (1989). Near-Death Experiences and the NMDA receptor. British Medical Journal, 298:1708.
13. Jansen, K. L. R. (2001). Ketamine: dreams and realities. Sarasota, Florida: MAPS.
14. Krippendorf, K. (2004). Content Analysis: an introduction to its methodology. 2nd edition, Thousand Oaks, CA: Sage.
15. McCambridge, J., Winstock, A., Hunt, N. (2007). 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. European Addiction Research, 13:57-64.
16. Moody, R. A. (1975). Life after life. Atlanta, Georgia: Mockingbird Books.
17. Morgan, C. J. A., Mofeez, A., Brandner, B., Bromley, L., Curran, V. (2004a). Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response study. Psychopharmacology (Berlin), 172:298-308.
18. Morgan, C. J. A., Mofeez, A., Brandner, B., Lesley, B., Curran, V. (2004b). Acute effects of ketamine in memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology, 29:208-218.
19. Morgan, C. J. A., Monaghan, L., Curran, V. (2004c). Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug. Addiction, 99:1450-1461.
20. Parnia, S., Waller, D. G., Yeates, R., Fenwick, P. (2001) A qualitative and quantitative study of the incidence, features and aetiology of near-death experiences in cardiac arrest survivors. Resuscitation, 48:149-156.
21. Perry, E. B., Jr., Cramer, J. A., Cho, H. S., Petrakis, I. L., Karper, L. P., Genovese, A., et al. (2007). Psychiatric safety of ketamine in psychopharmacology research. Psychopharmacology (Berlin), 192:253-260.
22. Persinger, M. (1983). Religious and mystical experiences as artefacts of temporal lobe function: a general hypothesis. Perceptual and Motor Skills, 57:1255-1262.
23. Pomarol-Clotet, E., Honey, G. D.,Murray, G. K. (2006). Psychological effects of ketamine in healthy volunteers: phenomenological study. British Journal of Psychiatry, 189:173-179.
24. Schifano, F., Corkery, J., Oyefeso, A., Tonia, T., Ghodse, A. H. (2008). Trapped in the 'K-hole';
25. overview of deaths associated with ketamine misuse in the UK (1993-2006). Journal of Clinical Psychopharmacology, 28:114-116.
26. Sehdev, R. S., Symmons, D. A., Kindl, K. (2006). Ketamine for rapid sequence induction in patients with head injury in the emergency department. Emergency Medicine Australasia, 18:37-44.
27. Smith, K.M., Larive, L. L., Romanelli, F. (2002). Club drugs:methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate. American Journal of Health-System Pharmacists, 59:1067-1076.
28. van Lommel, P., van Wees, R., Meyers, V., Elfferich, I. (2001). Near-Death experience in survivors of cardiac arrest: a prospective study in the Netherlands. The Lancet, 358:2039-2045.
29. Wolff, K., Winstock, A. R. (2006). Ketamine: from medicine to misuse. CNS Drugs, 20:199-218.